Friday, October 2, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· March 16, 2026

Tecan presents 2025 results and provides details on program to reignite profitable growth

View original at globenewswire.com
Tecan presents 2025 results and provides details on program to reignite profitable growth Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Tecan presents 2025 results and provides details on program to reignite profitable growth Financial results for the full year 2025 – Summary S…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Tecan expects to return to average organic growth rates in the mid- to high-single-digit percentage range in local currencies from 2029 onwards, while continuously improving profitability

    60% confidence
  • Tecan expects sales to increase in the low single-digit percentage range in local currencies for 2026

    60% confidence
  • Tecan intends to outgrow the market by leading its AI- and data-driven future

    60% confidence
  • Tecan forecasts adjusted EBITDA margin of 15.5% to 16.5% of sales for 2026, including 110 basis points headwind from FX and tariffs

    60% confidence
  • Our 2025 performance does not reflect Tecan's potential. We are acting decisively to change that. Our core is intact, and our balance sheet is strong.

    60% confidence
  • Tecan expects continued gradual improvement in end markets, with market growth increasing to a range of 1% to 3% in the years 2027-2028

    60% confidence
  • During 2025, demand for instruments in Academia & Government was significantly impacted by budget uncertainty and volatile public funding, particularly in the US and China

    60% confidence
  • Technology leadership and the ability to translate it into profitable growth are decisive, for customers and shareholders alike

    60% confidence
  • From 2029 onwards, Tecan assumes a return to normal market conditions, with market growth in the previous range of 3% to 5%

    60% confidence
  • The forces shaping the industry's future - AI integration, automation, scientific complexity, economic pressure - are powerful and durable and will drive significant growth in laboratory automation over the coming decade

    60% confidence
  • For 2026, Tecan expects end markets to recover gradually with market growth ranging from a moderate decline to moderate growth

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com